Evidence map›Paper›PMID 25838181›Full record

ArticlePLoS genetics2015

The Lowe syndrome protein OCRL1 is required for endocytosis in the zebrafish pronephric tubule.

Francesca Oltrabella, Grzegorz Pietka, Irene Barinaga-Rementeria Ramirez, Aleksandr Mironov, Toby Starborg, Iain A Drummond, Katherine A Hinchliffe, Martin Lowe

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 85 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Modelling Lowe syndrome and Dent-2 disease using zebrafish.Frontiers in cell and developmental biology · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Francesca OltrabellaFaculty of Life Sciences, University of Manchester, Manchester, United Kingdom.
Grzegorz PietkaFaculty of Life Sciences, University of Manchester, Manchester, United Kingdom.
Irene Barinaga-Rementeria RamirezFaculty of Life Sciences, University of Manchester, Manchester, United Kingdom.
Aleksandr MironovFaculty of Life Sciences, University of Manchester, Manchester, United Kingdom.
Toby StarborgFaculty of Life Sciences, University of Manchester, Manchester, United Kingdom.
Iain A DrummondNephrology Division, Massachusetts General Hospital and Department of Genetics, Harvard Medical School, Charlestown, Massachusetts, United States of America.
Katherine A HinchliffeFaculty of Life Sciences, University of Manchester, Manchester, United Kingdom.
Martin LoweFaculty of Life Sciences, University of Manchester, Manchester, United Kingdom.
University of Manchester · GBHarvard University · US

Funding

GENETIC ANALYSIS OF ZEBRAFISH KIDNEY DEVELOPMENTR01DK053093 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI DRUMMOND, IAIN A. · 1997 to 2018
$5.2M
NIDDK NIH HHS R01 DK053093Wellcome Trust 079615Wellcome Trust 088785
6 · The paper itself

Abstract

Lowe syndrome and Dent-2 disease are caused by mutation of the inositol 5-phosphatase OCRL1. Despite our increased understanding of the cellular functions of OCRL1, the underlying basis for the renal tubulopathy seen in both human disorders, of which a hallmark is low molecular weight proteinuria, is currently unknown. Here, we show that deficiency in OCRL1 causes a defect in endocytosis in the zebrafish pronephric tubule, a model for the mammalian renal tubule. This coincides with a reduction in levels of the scavenger receptor megalin and its accumulation in endocytic compartments, consistent with reduced recycling within the endocytic pathway. We also observe reduced numbers of early endocytic compartments and enlarged vacuolar endosomes in the sub-apical region of pronephric cells. Cell polarity within the pronephric tubule is unaffected in mutant embryos. The OCRL1-deficient embryos exhibit a mild ciliogenesis defect, but this cannot account for the observed impairment of endocytosis. Catalytic activity of OCRL1 is required for renal tubular endocytosis and the endocytic defect can be rescued by suppression of PIP5K. These results indicate for the first time that OCRL1 is required for endocytic trafficking in vivo, and strongly support the hypothesis that endocytic defects are responsible for the renal tubulopathy in Lowe syndrome and Dent-2 disease. Moreover, our results reveal PIP5K as a potential therapeutic target for Lowe syndrome and Dent-2 disease.

Indexed as

EndocytosisAnimalsCell PolarityEndosomesGene DeletionLow Density Lipoprotein Receptor-Related Protein-2Oculocerebrorenal SyndromePhosphoric Monoester HydrolasesPhosphotransferases (Alcohol Group Acceptor)PronephrosZebrafishZebrafish Proteins1-phosphatidylinositol-4-phosphate 5-kinaseLow Density Lipoprotein Receptor-Related Protein-2ocrl protein, zebrafishPhosphoric Monoester HydrolasesPhosphotransferases (Alcohol Group Acceptor)Zebrafish Proteins

Identifiers

PMID25838181
PMCPMC4383555
OpenAlexW2017641734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.